Clinical AI
AI Startup Targets Untapped Breast MRI Market as Dense Tissue Screening Rules Create Bottleneck"Catch cancer earlier": PinkStar's AI for breast MRI hopes to relieve overwhelmed sector
PinkStar Technologies is raising $3 million to bring the first FDA-cleared AI decision support tool for breast MRI to US radiologists struggling with surging scan volumes.
Health AI Central Editorial Team·August 31, 2026
Drug Discovery & Research
The Manufacturing Gap Threatening AI Drug Discovery's Promise
As AI-designed therapeutics reach human trials, venture capital firms warn that experimental validation and production capacity—not computational power—now determine which digital molecules become real medicines.
Health AI Central Editorial Team·July 31, 2026